跳到主要导航 跳到搜索 跳到主要内容

Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study

  • Taotao Wang
  • , Liyan Miao
  • , Hua Shao
  • , Xiaohua Wei
  • , Miao Yan
  • , Xiaocong Zuo
  • , Jun Zhang
  • , Xin Hai
  • , Guangjun Fan
  • , Wei Wang
  • , Linlin Hu
  • , Jian Zhou
  • , Yichang Zhao
  • , Yueliang Xie
  • , Jingjing Wang
  • , Sixun Guo
  • , Liu Jin
  • , Hao Li
  • , Hui Liu
  • , Quanfang Wang
  • Jiaojiao Chen, Sihan Li, Yalin Dong
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • The First Affiliated Hospital of Soochow University
  • Southeast University, Nanjing
  • Nanchang University
  • Central South University
  • Kunming Medical College
  • The First Affiliated Hospital of Harbin Medical University
  • Dalian Medical University
  • Liyang Hospital of Chinese Medicine

科研成果: 期刊稿件 › 文章 › 同行评审

36 引用 (Scopus)

摘要

Objectives: To characterize trough concentrations (Cmin) of voriconazole and associated hepatotoxicity, and to determine predictors of hepatotoxicity and identify high-risk groups in critically ill patients. Methods: This was a nationwide, multi-centre, retrospective study. Cmin and hepatotoxicity were studied from 2015 to 2020 in 363 critically ill patients who received voriconazole treatment. Logistic regression and classification and regression tree (CART) models were used to identify high-risk patients. Results: Large interindividual variability was observed in initial voriconazole Cmin and concentrations ranged from 0.1 mg/L to 18.72 mg/L. Voriconazole-related grade ≥2 hepatotoxicity developed in 101 patients, including 48 patients with grade ≥3 hepatotoxicity. The median time to hepatotoxicity was 3 days (range 1–24 days), and 83.2% of cases of hepatotoxicity occurred within 7 days of voriconazole initiation. Voriconazole Cmin was significantly associated with hepatotoxicity. The CART model showed that significant predictors of grade ≥2 hepatotoxicity were Cmin >3.42 mg/L, concomitant use of trimethoprim-sulfamethoxazole or tigecycline, and septic shock. The model predicted that the incidence of grade ≥2 hepatotoxicity among these high-risk patients was 48.3–63.4%. Significant predictors of grade ≥3 hepatotoxicity were Cmin >6.87 mg/L, concomitant use of at least three hepatotoxic drugs, and septic shock; the predictive incidence among these high-risk patients was 22.7–36.8%. Conclusion: Higher voriconazole Cmin, septic shock and concomitant use of hepatotoxic drugs were the strongest predictors of hepatotoxicity. Plasma concentrations of voriconazole should be monitored early (as soon as steady state is achieved) to avoid hepatotoxicity.

源语言英语
期刊论文编号106692
期刊International Journal of Antimicrobial Agents
卷60
期5-6
DOI
出版状态已出版 - 1 11月 2022
已对外发布是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study' 的科研主题。它们共同构成独一无二的学术指纹。

引用此